Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mike Greaves

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Thrombosis and Haemostasis|February 19, 2002
Limitations of the laboratory monitoring of heparin therapy. Scientific and Standardization Committee Communications: on behalf of the Control of Anticoagulation Subcommittee of the Scientific and Standardization Committee of the International Society of Thrombosis and HaemostasisMike Greaves,
Plos Medicine|October 20, 2005
Pharmacogenetics in the management of coumarin anticoagulant therapy: the way forward or an expensive diversion?Mike Greaves
Thrombosis Research|February 17, 2009
Pathogenesis and management of antiphospholipid syndromeMike Greaves
Vascular Medicine (London, England)|January 29, 2005
Acquired thrombophiliaMike Greaves
Thrombosis Research|January 26, 2011
Antiphospholipid syndrome: unusual clinical presentationsMike Greaves
Blood Reviews|January 31, 2006
Antiphospholipid syndrome: an evolving storyBeverley Robertson, Mike Greaves
British Journal of Haematology|April 2, 2014
The chequered history of the antiphospholipid syndromeDeepa Jayakody Arachchillage, Mike Greaves
Seminars in Thrombosis and Hemostasis|April 9, 2008
Can we predict bleeding?Henry G Watson, Mike Greaves
British Journal of Haematology|November 28, 2008
Screening and treatment for heritable thrombophilia in pregnancy failure: inconsistencies among UK early pregnancy unitsGillian Norrie, Roy G Farquharson, Mike Greaves
Journal of Vascular Surgery|August 17, 2005
Clopidogrel has no effect on D-dimer and thrombin-antithrombin III levels in patients with peripheral arterial disease undergoing peripheral percutaneous transluminal angioplastyKevin Cassar, Paul Bachoo, Isobel Ford, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Thrombosis and Haemostasis|February 19, 2002
Limitations of the laboratory monitoring of heparin therapy. Scientific and Standardization Committee Communications: on behalf of the Control of Anticoagulation Subcommittee of the Scientific and Standardization Committee of the International Society of Thrombosis and HaemostasisMike Greaves,
Plos Medicine|October 20, 2005
Pharmacogenetics in the management of coumarin anticoagulant therapy: the way forward or an expensive diversion?Mike Greaves
Thrombosis Research|February 17, 2009
Pathogenesis and management of antiphospholipid syndromeMike Greaves
Vascular Medicine (London, England)|January 29, 2005
Acquired thrombophiliaMike Greaves
Thrombosis Research|January 26, 2011
Antiphospholipid syndrome: unusual clinical presentationsMike Greaves
Blood Reviews|January 31, 2006
Antiphospholipid syndrome: an evolving storyBeverley Robertson, Mike Greaves
British Journal of Haematology|April 2, 2014
The chequered history of the antiphospholipid syndromeDeepa Jayakody Arachchillage, Mike Greaves
Seminars in Thrombosis and Hemostasis|April 9, 2008
Can we predict bleeding?Henry G Watson, Mike Greaves
British Journal of Haematology|November 28, 2008
Screening and treatment for heritable thrombophilia in pregnancy failure: inconsistencies among UK early pregnancy unitsGillian Norrie, Roy G Farquharson, Mike Greaves
Journal of Vascular Surgery|August 17, 2005
Clopidogrel has no effect on D-dimer and thrombin-antithrombin III levels in patients with peripheral arterial disease undergoing peripheral percutaneous transluminal angioplastyKevin Cassar, Paul Bachoo, Isobel Ford, et al.
Pageof 2